Geode Capital Management’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SGMT
Geode Capital Management's SGMT Position: Q3 2026 in Review
Geode Capital Management increased its Sagimet Biosciences (SGMT) stake by 6.9% in Q3 2026, buying an estimated $916K and bringing the position to 1,543,687 shares worth $15.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2266.
Geode Capital Management first reported a position in SGMT in Q3 2023 and has held it in 13 quarters since. 152 funds tracked by Wall St. Rank hold SGMT as of Q3 2026.
- Geode Capital Management held 1,543,687 shares of Sagimet Biosciences worth $15.3M as of Q3 2026.
- Geode Capital Management bought 99,668 Sagimet Biosciences shares in Q3 2026, an estimated $916K.
- Sagimet Biosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #2266 holding.
- Geode Capital Management first reported a position in Sagimet Biosciences in Q3 2023 and has held it in 13 quarters since.
- 152 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.